Lhasa Limited

shared knowledge shared progress

ABOUT US |
CONTACT US |
CAREERS |
Login

Related News

Nitrites in Excipients data release: Supporting more scientifically driven nitrosamine risk assessments
Lhasa Limited is pleased to announce the release of the 2022.1 Nitrites in Excipients database.
17 May 2022
Lhasa Limited’s Elemental Impurities Database is now open for all to join
29 April 2022
Vitic 2022.1 data release: A high quality source for toxicity data
10 February 2022

Related Blog Articles

The benefits of joining the Complex Nitrosamines consortium
Read what one of our Complex Nitrosamines Data Sharing Initiative members, Graham Smith, Oncology Chemical Toxicology Lead at AstraZeneca, has to say about being involved in this growing consortium!
10 October 2022
Nitrites in Excipients Data Sharing Consortium: Supporting Nitrosamine Risk Assessment
22 February 2022
20 tips for nitrosamine impurity assessment
05 August 2021

Recent News

Lhasa Limited announces the anticipated release of Zeneth 9
Lhasa Limited is thrilled to announce the anticipated release of Zeneth version 9, our in silico software solution for the identification of forced degradation pathways of organic compounds.
30 November 2022

Recent Blog Articles

A day in the life of a Business Support Manager at Lhasa Limited
Hello, my name is Oana Leonte, and I work in the Business Support Team at Lhasa Limited as a Business Support Manager.

In my role I provide support to many different functions across the organisation, this includes our Marketing, Applied Sciences and Business Partnerships teams. My role is very varied and relies on attention to detail and organisational skills to accommodate travel bookings and events planning, amongst other areas of support.

Read on to discover what a day in the life of a Business Support Manager at Lhasa can look like!
24 November 2022

Recent Publications

Strategies for Assessing Acceptable Intakes for Novel N-Nitrosamines Derived from Active Pharmaceutical Ingredients
November 2022
Improvements to in silico skin sensitisation predictions through privacy-preserving data sharing
November 2022Derek Nexus
The Landscape of Potential Small and Drug Substance Related Nitrosamines in Pharmaceuticals
November 2022Complex Nitrosamines

Upcoming Events

2022 How to resolve inconclusive predictions from defined approaches for skin sensitisation in OECD GL No. 497
Dec 8 2022

Recent News

Lhasa Limited announces the anticipated release of Zeneth 9
Lhasa Limited is thrilled to announce the anticipated release of Zeneth version 9, our in silico software solution for the identification of forced degradation pathways of organic compounds.
30 November 2022
Lhasa Limited announce promising Federated Learning Hackathon midpoint results
24 November 2022
Structurally complex and API-like nitrosamine data added to the Complex Nitrosamines Database
11 August 2022

Recent Blog Articles

A day in the life of a Business Support Manager at Lhasa Limited
Hello, my name is Oana Leonte, and I work in the Business Support Team at Lhasa Limited as a Business Support Manager.

In my role I provide support to many different functions across the organisation, this includes our Marketing, Applied Sciences and Business Partnerships teams. My role is very varied and relies on attention to detail and organisational skills to accommodate travel bookings and events planning, amongst other areas of support.

Read on to discover what a day in the life of a Business Support Manager at Lhasa can look like!
24 November 2022
How to calculate the safe limit for carcinogens as per ICH M7
07 November 2022
Leeds Digital Festival award winners
18 October 2022

Archive

This is a library of Lhasa's blog articles.

less than 10 minutes
Trusting expert derived knowledge; an overview of alert creation in Derek Nexus
Derek Nexus contains alerts which predict the potential toxicity of a compound, this article explains how Lhasa scientists create alerts which are trustworthy and accurate.
- Science
20 May 2021
5 minutes
Lhasa Limited supports an international initiative in the fight against COVID-19
Coronaviruses are a large family of viruses which can affect humans or other species and can range anywhere from a mild illness such as the common cold to more severe illnesses such as Severe Acute Respiratory Syndrome (SARS). Coronavirus disease 2019 (COVID-19) is an infectious disease caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
- Innovation
- Initiatives
25 June 2020

Sitemap

© 2022 Lhasa Limited | Registered office: Granary Wharf House, 2 Canal Wharf, Leeds, LS11 5PS, UK Tel: +44 (0)113 394 6020
VAT number 396 8737 77 | Lhasa Limited is registered as a charity (290866)| Company Registration Number 01765239 (England and Wales).

Apart from the free survey software, we also have access to QuestionPro's free survey templates . We've found many of them useful and powerful to collect insights from various stakeholders of our organization.